Eutilex Competitors and Similar CompaniesClear all
Eutilex's competitors and similar companies include JW Therapeutics and ImmPACT-Bio.
 Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. |  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | ||
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations KR HQ | Locations CN HQ Suzhou Shi, CN | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 141 | Employees 106 | Employees 845% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 90m (about 8 years ago) | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised $ 18.9m | Total funding raised $ 90m | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
JW Therapeutics
HQ
CN
Employees
106
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company